Potential candidate biomarkers for heterogeneity in triple-negative breast cancer (TNBC)

被引：0
|
作者：
Eun Yoon Cho
Myung Hee Chang
Yoon La Choi
Jeong Eon Lee
Seok Jin Nam
Jung-Hyun Yang
Yeon Hee Park
Jin Seok Ahn
Young-Hyuck Im
机构：
[1] Sungkyunkwan University School of Medicine,Division of Hematology
[2] Sungkyunkwan University School of Medicine,Oncology, Department of Medicine, Samsung Medical Center
[3] Sungkyunkwan University School of Medicine,Department of Pathology, Samsung Medical Center
来源：
Cancer Chemotherapy and Pharmacology | 2011年 / 68卷
关键词：
Triple-negative breast cancer; Relapse-free survival; BRCA1; EGFR;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：753 / 761
页数：8
相关论文
共 50 条
  • [1] Potential candidate biomarkers for heterogeneity in triple-negative breast cancer (TNBC)
    Cho, Eun Yoon
    Chang, Myung Hee
    Choi, Yoon La
    Lee, Jeong Eon
    Nam, Seok Jin
    Yang, Jung-Hyun
    Park, Yeon Hee
    Ahn, Jin Seok
    Im, Young-Hyuck
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (03) : 753 - 761
  • [2] Triple-negative breast cancer (TNBC) phosphoproteomics
    Gaitero, Sara Fernandez
    Zagorac, Ivana
    Lopez-Acosta, Jose Francisco
    Gomez-Lopez, Gonzalo
    Pisano, David Gonzalez
    Peralta, Javier Munoz
    Manso, Luis
    Alonso, Soledad
    Penning, Renske
    Altelaar, Maarten
    Heck, Albert J. R.
    Quintela-Fandino, Miguel
    [J]. CANCER RESEARCH, 2017, 77
  • [3] Candidate predictive biomarkers of cetuximab benefit in triple-negative breast cancer
    Khambata-Ford, S.
    O'Shaughnessy, J.
    Brickman, D.
    Jensen, J. D.
    Asmar, L.
    Horak, C. E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [4] The Role of Immunotherapy in Triple-Negative Breast Cancer (TNBC)
    Michaels, Elena
    Chen, Nan
    Nanda, Rita
    [J]. CLINICAL BREAST CANCER, 2024, 24 (04) : 263 - 270
  • [5] Neoadjuvant treatments for triple-negative breast cancer (TNBC)
    von Minckwitz, G.
    Martin, M.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 35 - 39
  • [6] Phosphoproteomic portraits of triple-negative breast cancer (TNBC)
    Quintela-Fandino, Miguel
    Zagorac, Ivana
    Lopez-Acosta, Jose Francisco
    Gomez, Gonzalo
    Pisano, David G.
    Munoz, Javier
    Manso, Luis
    Alonso, Soledad
    Penning, Renske
    Altelaar, Maarten
    Heck, Albert J. R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [7] Lipogenesis inhibition in triple-negative breast cancer (TNBC)
    Giro-Perafita, Ariadna
    Palomeras, Sonia
    Polonio, Emma
    Ciurana, Joaquim
    Vinas, Gemma
    Puig, Teresa
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2017, 40 : S58 - S58
  • [8] Biomarkers Expression in Triple Negative Breast Cancer (TNBC)
    Nofech-Mozes, Sharon
    Han, Rachel
    Olkhov-Mitsel, Ekaterina
    Lu, Fang-I
    Plotkin, Anna
    Hanna, Wedad
    Slodkowska, Elzbieta
    [J]. MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 135 - 137
  • [9] Biomarkers Expression in Triple Negative Breast Cancer (TNBC)
    Nofech-Mozes, Sharon
    Han, Rachel
    Olkhov-Mitsel, Ekaterina
    Lu, Fang-I
    Plotkin, Anna
    Hanna, Wedad
    Slodkowska, Elzbieta
    [J]. LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 135 - 137
  • [10] Subtyping of triple-negative breast cancer (TNBC): A cohort study
    Thomssen, Christoph
    Hartung, Caroline
    Porsch, Martin
    Stuckrath, Kathrin
    Buchmann, Jorg
    Kantelhardt, Eva J.
    Vetter, Martina
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345